A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines

Abstract Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation wi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yamato Wada, Arnone Nithichanon, Eri Nobusawa, Leonard Moise, William D. Martin, Norio Yamamoto, Kazutaka Terahara, Haruhisa Hagiwara, Takato Odagiri, Masato Tashiro, Ganjana Lertmemongkolchai, Haruko Takeyama, Anne S. De Groot, Manabu Ato, Yoshimasa Takahashi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/592d0fec53c8484cb924caf5ee652856
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:592d0fec53c8484cb924caf5ee652856
record_format dspace
spelling oai:doaj.org-article:592d0fec53c8484cb924caf5ee6528562021-12-02T12:32:33ZA humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines10.1038/s41598-017-01372-52045-2322https://doaj.org/article/592d0fec53c8484cb924caf5ee6528562017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01372-5https://doaj.org/toc/2045-2322Abstract Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the human genome, the links between the T-cell epitopes and low immunogenicity of H7 HA remains unknown due to the lack of animal models reproducing the response observed in humans. Here, we utilized a humanized mouse model to recapitulate the low immunogenicity of H7 HA. Our analysis demonstrated that modification of a single H7 epitope by changing 3 amino acids so that it is homologous with a known H3 immunogenic epitope sequence significantly improved the immunogenicity of the H7 HA in the humanized mouse model, leading to a greater than 4-fold increase in HA-binding IgG responses. Thus, we provide experimental evidence for the important contribution of this H7-specific T cell epitope in determining the immunogenicity of an influenza vaccine. Furthermore, this study delineates strategies that can be used for screening and selecting vaccine strains using immunoinformatics tools and a humanized mouse model.Yamato WadaArnone NithichanonEri NobusawaLeonard MoiseWilliam D. MartinNorio YamamotoKazutaka TeraharaHaruhisa HagiwaraTakato OdagiriMasato TashiroGanjana LertmemongkolchaiHaruko TakeyamaAnne S. De GrootManabu AtoYoshimasa TakahashiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yamato Wada
Arnone Nithichanon
Eri Nobusawa
Leonard Moise
William D. Martin
Norio Yamamoto
Kazutaka Terahara
Haruhisa Hagiwara
Takato Odagiri
Masato Tashiro
Ganjana Lertmemongkolchai
Haruko Takeyama
Anne S. De Groot
Manabu Ato
Yoshimasa Takahashi
A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines
description Abstract Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the human genome, the links between the T-cell epitopes and low immunogenicity of H7 HA remains unknown due to the lack of animal models reproducing the response observed in humans. Here, we utilized a humanized mouse model to recapitulate the low immunogenicity of H7 HA. Our analysis demonstrated that modification of a single H7 epitope by changing 3 amino acids so that it is homologous with a known H3 immunogenic epitope sequence significantly improved the immunogenicity of the H7 HA in the humanized mouse model, leading to a greater than 4-fold increase in HA-binding IgG responses. Thus, we provide experimental evidence for the important contribution of this H7-specific T cell epitope in determining the immunogenicity of an influenza vaccine. Furthermore, this study delineates strategies that can be used for screening and selecting vaccine strains using immunoinformatics tools and a humanized mouse model.
format article
author Yamato Wada
Arnone Nithichanon
Eri Nobusawa
Leonard Moise
William D. Martin
Norio Yamamoto
Kazutaka Terahara
Haruhisa Hagiwara
Takato Odagiri
Masato Tashiro
Ganjana Lertmemongkolchai
Haruko Takeyama
Anne S. De Groot
Manabu Ato
Yoshimasa Takahashi
author_facet Yamato Wada
Arnone Nithichanon
Eri Nobusawa
Leonard Moise
William D. Martin
Norio Yamamoto
Kazutaka Terahara
Haruhisa Hagiwara
Takato Odagiri
Masato Tashiro
Ganjana Lertmemongkolchai
Haruko Takeyama
Anne S. De Groot
Manabu Ato
Yoshimasa Takahashi
author_sort Yamato Wada
title A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines
title_short A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines
title_full A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines
title_fullStr A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines
title_full_unstemmed A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines
title_sort humanized mouse model identifies key amino acids for low immunogenicity of h7n9 vaccines
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/592d0fec53c8484cb924caf5ee652856
work_keys_str_mv AT yamatowada ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT arnonenithichanon ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT erinobusawa ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT leonardmoise ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT williamdmartin ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT norioyamamoto ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT kazutakaterahara ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT haruhisahagiwara ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT takatoodagiri ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT masatotashiro ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT ganjanalertmemongkolchai ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT harukotakeyama ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT annesdegroot ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT manabuato ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT yoshimasatakahashi ahumanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT yamatowada humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT arnonenithichanon humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT erinobusawa humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT leonardmoise humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT williamdmartin humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT norioyamamoto humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT kazutakaterahara humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT haruhisahagiwara humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT takatoodagiri humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT masatotashiro humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT ganjanalertmemongkolchai humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT harukotakeyama humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT annesdegroot humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT manabuato humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
AT yoshimasatakahashi humanizedmousemodelidentifieskeyaminoacidsforlowimmunogenicityofh7n9vaccines
_version_ 1718394036008517632